The University of Hong Kong has Developed a Nasal Spray New Coronavirus Vaccine and Approved to Start Clinical Trials

The nasal spray new coronavirus vaccine developed by the University of Hong Kong has been approved for clinical trials.

New coronavirus pneumonia is raging around the world, and vaccines are being actively developed everywhere. The State Key Laboratory of Emerging Infectious Diseases in the Department of Microbiology, School of Medicine, University of Hong Kong, announced on the 9th that it has developed a new coronavirus vaccine with Xiamen University in China and Beijing Wantai Biotechnology for influenza virus vectors. It has been approved by the China's National Medical Products Administration to carry out clinical trials and has become the only nasal spray new coronavirus vaccine currently in clinical trials.

A spokesperson for the University of Hong Kong pointed out that since the outbreak of the new coronary pneumonia, the research team has used the vaccine technology platform to prepare vaccine seeds within a short period of time. Related vaccine seeds can be used similar to the chicken embryo production system, cell factory, or cell fermentation for preparing influenza virus vaccine. A large number of tanks are cultivated, and the prepared harmless live vaccine can be operated in a nasal spray mode, which is a multifunctional vaccine that can simultaneously target the new coronavirus and influenza virus.

The University of Hong Kong continued that the relevant vaccine research project has received support from the Ministry of Science and Technology in the Mainland. It is one of the five key vaccine technology strategies in the Mainland. The nasal spray influenza virus vector new coronavirus vaccine produced by the team has passed the emergency approval of the National Medical Products Administration, to carry out clinical trials. It is currently the only vaccine that has been approved to carry out clinical trials for new coronary pneumonia vaccine candidates that adopts nasal spray vaccination. It is safe and convenient to use, and can be highly targeted by simulating the natural infection route of respiratory viruses.